Wound Care Biologics Market is expanding rapidly as Organogenesis Holdings Inc. launches advanced wound care innovations including PuraPly AM, NuShield, Apligraf, and Affinity
Wound Care Biologics is scientifically designed products that are utilized for remedying non-healing wounds without affecting the body's natural repair processes. It also involves the application of specific active pharmaceutical proteins like different plant-based active proteins that exhibit super antibody and cell-penetrating abilities. One of the primary applications of wound care biologics in severe injuries occurred during burn incidents or road accidents. As per the World Health Organization (WHO), every year, around 1.35 million people die due to road traffic crash, while 50 million suffer from non-fatal injuries and many suffer a disability. Wound care biologics are intended to provide reestablishment of the essential repair mechanism. Thus, such factors can augment growth of the wound care biologics market. Another key factor that could govern the development of the Wound Care Biologics Market is rapidly growing geriatric population. Elderly people are